FDA approves gene-targeting skin cancer drug (AP)
AP – The Food and Drug Administration has approved a first-of-a-kind drug to treat the deadliest form of skin cancer by targeting a particular genetic mutation found in about half of patients.
Good Health is Your Greatest Wealth……Virgil
AP – The Food and Drug Administration has approved a first-of-a-kind drug to treat the deadliest form of skin cancer by targeting a particular genetic mutation found in about half of patients.
Since the 1970s, the US Food and Drug Administration has required labels to state that the hormone "is not an effective adjunctive therapy" for weight loss. If dieters lose weight on the regimen, the effect is from the ultralow-calorie diet, … See all stories on this topic ยป |
Chicago Tribune |
ContributorNetwork – Fruta Planta, Passion Coffee and Rock Hard Extreme, marketed as dietary supplements, weight loss products, energy boosters and sexual enhancement products have been recalled for unlisted Sulfoaildenafil (steroid) and Food and Drug Administration unapproved sibutramine.
HealthDay – THURSDAY, July 21 (HealthDay News) — Brilinta (ticagrelor) has
been approved by the U.S. Food and Drug Administration to help reduce the
risk of heart attack and cardiovascular death among people with acute
coronary syndromes (ACS).
HealthDay – WEDNESDAY, July 20 (HealthDay News) — In a long-awaited move,
the U.S. Food and Drug Administration late Wednesday approved the blood
thinner Brilinta (ticagrelor) for use in patients with acute coronary
syndromes, to help lower their odds for heart attack and death.